Literature DB >> 15117565

Prostaglandins F2alpha and E2 in aqueous humor of patients with cataract surgery.

Toshihiko Matsuo1.   

Abstract

To understand the role of prostaglandins F(2alpha) and E(2) in aqueous humor under the normal condition, their concentrations were measured by enzyme immunoassay in aqueous fluid obtained from either eye of 60 patients during cataract surgery and correlated with clinical factors as the age and intraocular pressure. The concentrations of prostaglandin F(2alpha) in the aqueous of all patients were below the level of detection. The concentrations of prostaglandin E(2) in the aqueous were below the level of detection in 37 patients while ranged from 9 to 48 pg/mL (median, 31) in 23 patients. The levels of prostaglandin E(2) did not have correlation with the age of the patients or the intraocular pressure of the eyes. In conclusions, the concentrations of prostaglandin E(2) were apparently higher than the concentrations of prostaglandin F(2alpha) in the aqueous. This study could not prove the relationship between prostaglandin levels and the intraocular pressure or the age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117565     DOI: 10.1089/108076804773710768

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  3 in total

1.  Can NSAIDs and prostaglandin analogues be combined?

Authors:  A Alm
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

2.  Comparative lipidomic analysis of inflammatory mediators in the aqueous humor and tear fluid of humans and rabbits.

Authors:  Dmitry V Chistyakov; Nadezhda V Azbukina; Alina A Astakhova; Sergei V Goriainov; Viktor V Chistyakov; Veronika V Tiulina; Viktoriia E Baksheeva; Vladislav I Kotelin; Elena V Fedoseeva; Andrey A Zamyatnin; Pavel P Philippov; Olga A Kiseleva; Alexander M Bessmertny; Ivan I Senin; Elena N Iomdina; Marina G Sergeeva; Evgeni Yu Zernii
Journal:  Metabolomics       Date:  2020-02-12       Impact factor: 4.290

3.  Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.

Authors:  Román A Barraza; Jay W McLaren; Eric M Poeschla
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.